Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients

J Clin Oncol. 2008 Feb 1;26(4):517-8. doi: 10.1200/JCO.2007.14.3156.
No abstract available

Publication types

  • Comment
  • Editorial
  • Introductory Journal Article

MeSH terms

  • Benchmarking
  • Clinical Trials, Phase III as Topic
  • Humans
  • Melanoma / mortality*
  • Melanoma / pathology
  • Melanoma / secondary
  • Melanoma / therapy*
  • Neoplasm Staging
  • Prognosis
  • Research Design / standards
  • Sample Size
  • Skin Neoplasms / mortality*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*